Healthcare & Life Sciences
Poxel
Francewww.poxel.com/
Poxel is a Healthcare & Life Sciences startup based in France, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Poxel
Poxel is a company headquartered in France. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Poxel is a French biopharmaceutical company focused on developing innovative therapeutic products for metabolic diseases, including type 2 diabetes and non-alcoholic steatohepatitis (NASH). Their lead product, Twymeeg (Imeglimin), is approved for type 2 diabetes in Japan.
Explore Poxel's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.